SUMMARY A patient with acid maltase deficiency was treated with a high protein diet for 7 months. Protein turnover expressed in terms of lean body mass was shown to be increased in this patient before the diet but was markedly reduced following the diet. The patient improved clinically whilst on the diet both subjectively and in terms of mobility, breathing and reduced peripheral cyanosis at rest.
The adult form of acid maltase (ax 1-4 glucosidase) deficiency is characterised by progressive muscle weakness which can lead to acute respiratory failure. This weakness has been attributed to disruption of muscle fibres due to accumulation of glycogen. Glycogen accumulates in the lysosomes but also occurs in increased amounts in the sarcoplasm which suggests that some lysosomes may rupture as a result of overdistension.' Since disruption of lysosomes would also result in the release of autolytic enzymes the muscle weakness may result from increased tissue breakdown.
In a patient with the childhood form of the disease which is more severe than the adult form, Slonim et al2 have demonstrated that the clearance of branched chain amino acids following protein ingestion is more rapid than in normal children, suggesting abnormal protein metabolism. Treatment of the patient with a high protein diet for 12 months reduced to normal the clearance of branched chain amino acids following protein ingestion and resulted in improved muscle function and strength. In the current study we have measured protein synthesis and degradation using 1-'4C leucine in a patient with the adult form of acid maltase deficiency both before and after 7 months of a high protein diet. A full metabolic profile of the patient was also obtained and the response to an oral glucose tolerance test and 36 hour starvation was investigated.
A detailed clinicopathological account of this patient has been published (case 1, ref 3) . At the time of study the patient was 33 years old. She was one of two sisters born to parents who were first cousins. Following normal early developmental milestones she noticed that her gait was abnormal at the age of 22 years and had symptoms suggestive of nocturnal respiratory insufficiency, aged 27. By the age of 30, she required nocturnal respiratory support on a rocking bed. On examination she was 183cm tall and weighed 62kg. She walked slowly, but unaided, with a marked pelvic waddle. There was severe truncal and pelvic girdle weakness, mild proximal limb weakness with normal cranial and bulbar function, preserved reflexes and flexor plantar responses: the respiratory muscles were weak and the diaphragms paralysed.
Biopsy of vastus lateralis showed the typical features of acid maltase deficiency with marked vacuolation of most fibres and glycogen accumulation (5-5% wet weightnormal up to 1%). The enzyme deficiency was confirmed biochemically in muscle and cultured skin fibroblasts (Professor A D Patrick, Enzyme Research Laboratory, Institute of Child Health).
Methods
The patients' usual daily caloric intake of approximately 2,000 calories (186 g carbohydrate, 104 g fat, 78 g protein) was maintained for the first part of the study. She was admitted for 14 Expired '4CO2 was measured by the method of Kaihara and Wagner9 and per cent CO2 on an infra-red capnograph (Godart NV, Bilthoven, Holland).
In the acid maltase patient leucine turnover was calculated from: Infusion rate of '4C leucine (dpm/min/kg body weight)/steady state level of leucine specific activity (dpm/pmol) and in the control subjects from: Dose of isotope injected/area under leucine specific activity curve. Leucine metabolism was calculated using the standard stochastic model"0 in which leucine turnovet (QL) = S + 0 = B + I where S = rate of leucine incorporation into protein; 0 = rate of leucine oxidation; B = rate of leucine entering the plasma pool from protein breakdown and I = rate of dietary intake. Since the patient and control subjects were studied after an overnight fast I = zero. Estimates of protein synthesis and degradation were calculated from S and B respectively on the assumption that the leucine content of mixed body protein is 8%. Leucine oxidation rate (0) was calculated from the equation: Leucine oxidation rate (pmol/min/kg) = CO2 production rate (mmol/min) x "CO2 Dose Leucine turnover (jrmol/min/kg) where '4CO2 = steady state level "4C02 (dpm/mmol) in the acid maltase patient or area under "4CO2 curve (dpm/mmol x min) in the normal subjects and Dose = 14C leucine infusion rate (dpm/min) in the patient or 14C leucine injected (dpm) in the control subjects. Leucine metabolic clearance rate was calculated from: Leucine MCR (ml/min/kg) = Leucine turnover (Jumol/min/kg) Leucine concentration (umol/ml) Muscle mass and lean body mass were calculated from the rate of creatinine excretion." 12 In the control subjects, lean body mass was calculated from age, weight and height of the patients. 3 The patient was assessed at intervals using a standard performance scale,'4 including timed walking over 30 metres, muscle strength'5 and supine/standing vital capacity measurements.
Results
The patient had normal postabsorptive levels of metabolites, amino acids and insulin as shown in table 1. The patient showed a normal response to an oral glucose tolerance test (fig 1) and to the 36 hour fast with the exception of alanine concentration which decreased markedly by 50% compared to 17% in normal subjects (table 1) .
Urinary creatinine excretion was reduced compared to normal women (table 2), despite renal creatinine clearance being normal (97 ml/min). Excretion of 3 methyl-histidine was normal but when expressed in terms of creatinine excretion (that is, 3 methylhistidine/creatinine x 103) was twice normal.
Leucine turnover, metabolic clearance rate (MCR), oxidation rate and derived measurements of protein synthesis were normal when expressed in terms of body weight (table 3) . However lean body mass in this patient calculated from the rate of creatinine excretion was considerably reduced. When expressed in terms of lean body mass leucine turnover, MCR, protein synthesis and protein degradation rates were above the limits of the range seen in control subjects. There was a small decrease in 3 methyl-histidine excretion rate and the 3 methyl-histidine/creatinine ratio was reduced. Leucine turnover and rates of whole body protein synthesis and degradation were decreased below normal levels when expressed in terms of body weight. Leucine oxidation rate had not changed when expressed as a function of body weight or lean body mass. When looked at in terms of lean body mass leucine turnover and rates of whole body protein synthesis and degradation had fallen and were now similar to the rates found in control subjects. Leucine MCR was also reduced but was still greater than in control subjects.
The patient improved clinically whilst on the high protein diet both subjectively and in terms of general mobility, breathing (fig 2) and reduced peripheral cyanosis at rest. The mean time taken to walk 30 metres was 73s (range 50-110) on the six occasions before treatment and 32 s (range 28-35) on the last six consecutive occasions [7] [8] [9] [10] [11] [12] [13] [14] [15] months after the start of the diet. There was no improvement in muscle strength in the eight groups measured (right and left shoulder abduction, right elbow flexion/extension, right hip flexion, right and left knee extension, neck flexion), but a small systematic increase in supine vital capacity from 0 45 to 0-81 was noted.
Discussion
The normal response to an oral glucose tolerance test and a 36 hour fast demonstrated that there was no apparent defect in glucose metabolism in this patient. Unlike control subjects who showed only a small decrease in alanine concentration after a 36 hour fast, the plasma alanine concentration of this patient fell markedly. This suggests that either hepatic uptake of alanine for gluconeogenesis was increased or that ala- Acid maltase deficiency tissues other than muscle are not clinically affected by the disorder, the increase in whole body protein degradation/kg lean body mass is probably due to increased muscle proteolysis. This may result from the accumulation of muscle glycogen causing the disruption of lysosomes and the release of autolytic enzymes.' Alternatively because lean body mass is reduced, protein degradation may be increased to maintain a normal supply of amino acids to other tissues. The increased protein synthesis could be a compensatory increase.
An alternative measure of muscle protein breakdown which has been widely used is urinary excretion of 3 methyl-histidine. 17 18 This amino acid, formed by the methylation of peptide-bound histidine in actin and myosin, is excreted when these proteins are broken down and is not re-used for protein synthesis. As a major fraction of creatinine excretion is proportional to muscle mass" the 3 methylhistidine/creatinine ratio in the urine describes the relationship between muscle catabolism/muscle mass. In this patient the 3 methyl-histidine/creatinine ratio was nearly twice normal. This also suggests the increased whole body protein degradation (expressed as lean body mass) was due to an increased muscle proteolysis. It has, however, been suggested that 3 methyl-histidine is not a good measure of muscle protein breakdown since actin and myosin are also found in skin and gastrointestinal tract.
Although muscle mass and lean body mass were still lower than normal after treatment with a high protein diet for 7 months, whole body protein synthesis and degradation rate (expressed as lean body mass) was reduced to normal and 3 methyl histidine/creatinine ratio was decreased. It is not clear how the high protein diet may have reduced whole body protein degradation. Possibly the supply of an alternative amino acid source spares muscle protein.
The decrease in synthesis is probably a compensatory decrease, secondary to the fall in degradation.
Patients with acid maltase deficiency may be functionally limited by respiratory muscle insufficiency as in this case. The improvement in mobility following treatment with a high protein diet was probably secondary to enhanced respiratory function which was critically reduced. It seems plausible that respiratory muscles (those most selectively and severely affected by the disease) might, through only a small gain in contractile strength, improve ventilation sufficiently to increase wellbeing and mobility. More precise measurements utilising transdiaphragmatic measurements and inspiratory/expiratory pressure measurements may clarify this. If such were the case only a small shift in muscle protein turnover in favour of net synthesis might be required for significant clinical movement.
A high protein diet has been shown to be beneficial 591 in a patient with the childhood form of acid maltase deficiency.2 It is interesting that a high protein diet has also been found to improve a patient with
McArdle's syndrome'9, another disease which results in muscle wasting.
The response of the patient with acid maltase deficiency in the present study to the high protein diet endorses and extends the observations of Slonim et al' and indicates the need for more extensive trials of high protein diet in this previously untreatable condition. These are currently being undertaken.
